VeriChip Adds 65 Hospitals/Emergency Departments to its VeriMed Network on

First Day of AAEM Conference

    DELRAY BEACH, Fla., March 13 /PRNewswire-FirstCall/ -- VeriChip
 Corporation (Nasdaq:   CHIP), a provider of RFID systems for healthcare and
 patient-related needs, announced today that 65 new hospitals have agreed to
 participate in the VeriMed Patient Identification System network at the
 American Academy of Emergency Medicine (AAEM) 13th Annual Scientific
 Assembly conference in Las Vegas, bringing the Company's total number of
 enrolled hospitals to more than 500.
     Scott R. Silverman, Chairman and CEO of VeriChip, commented, "We are
 very pleased to add 65 new hospitals to our network on day one of this
 three-day conference. Furthermore, we are proud to achieve a significant
 milestone in our infrastructure build-out. With more than 500 hospitals now
 enrolled in the VeriMed Patient Identification System, we are well on our
 way to meeting our stated year-end goal of 800 hospitals in the VeriMed
 network."
     The VeriMed Patient Identification System, which consists of a
 hand-held radio frequency identification (RFID) scanner, an implantable
 RFID microchip, and a secure patient database, is being used to help
 rapidly identify and provide access to important health information on
 participating patients.
     The new healthcare facilities agreed to use the VeriMed reader as
 standard protocol to scan patients that arrive in emergency rooms
 unconscious, delirious or confused. The Company continues to provide
 readers to hospitals and other healthcare facilities at no charge as part
 of its efforts to "seed" the infrastructure for the VeriMed patient
 identification system.
     About VeriChip Corporation
     VeriChip Corporation, headquartered in Delray Beach, Florida, develops,
 markets and sells radio frequency identification, or RFID, systems used to
 identify, locate and protect people and assets. VeriChip's goal is to
 become the leading provider of RFID systems for people in the healthcare
 industry. VeriChip sells passive RFID systems for identification purposes
 and active RFID systems for local-area location and identification
 purposes. VeriChip recently began to market its VeriMed(TM) Patient
 Identification System for rapidly and accurately identifying people who
 arrive in an emergency room and are unable to communicate. This system uses
 the first human-implantable passive RFID microchip, the implantable
 VeriChip(TM), cleared for medical use in October 2004 by the United States
 Food and Drug Administration.
     VeriChip Corporation is majority-owned by Applied Digital Inc. (Nasdaq:  
 ADSX), which also owns a majority position in Digital Angel Corporation
 (Amex:   DOC). For more information on VeriChip, please call 1-800- 970-2447,
 or email info@verichipcorp.com. Additional information can be found online
 at www.verichipcorp.com.
     Statements about the Company's future expectations, including future
 revenues and earnings, and all other statements in this press release other
 than historical facts are "forward-looking statements" within the meaning
 of Section 27A of the Securities Act of 1933, Section 21E of the Securities
 Exchange Act of 1934, and as that term is defined in the Private Litigation
 Reform Act of 1995. Such forward-looking statements involve risks and
 uncertainties and are subject to change at any time, and the Company's
 actual results could differ materially from expected results. The Company
 undertakes no obligation to update forward-looking statements to reflect
 subsequently occurring events or circumstances.
     Contact:
      VeriChip Corporation
      Allison Tomek
      561-805-8000
      atomek@adsx.com
 
     The Ruth Group
      Nick Laudico (investors)
      (646) 536-7030
      nlaudico@theruthgroup.com
 
      Jason Rando (media)
      (646) 536-7025
      jrando@theruthgroup.com
 
 

SOURCE VeriChip Corporation

Back to top